Stratum Nutrition, Adare Biome enter U.S. distribution agreement for postbiotic ingredient

Photo © iStockphoto.com/Raycat

Stratum Nutrition (Carthage, MO) and Adare Biome entered into a North American distribution agreement for LBiome (Lactobacillus LB), a postbiotic for digestive health composed of two human-origin strains that have been heat-stabilized with its culture medium. 

“Postbiotics are an emerging category of biotics in the microbiome space, having shown very interesting properties and benefits in which Adare Biome has an expertise as an organization in that area,” said Frederic Appert, vice president and business unit leader at Adare Biome, in a press release. “We are excited to be partnering with Stratum Nutrition to make our technology available in the U.S. dietary supplement market.”

Research supports LBiome cells’ ability to adhere to intestinal epithelial cells (the type of cells that line the gut) and strengthen the connections (tight junctions) between these cells. It has been shown to rapidly calm lower gastrointestinal upset.

“It is exciting to enter the digestive health category by bringing a unique ingredient for gut health into Stratum’s highly selective portfolio,” said Micah Osborne, president of Stratum Nutrition, in a press release. “As more customers want alternative delivery options with human-derived strains, we see big opportunities for this health category and look forward to sharing with the industry the efficacy and flexibility of the postbiotic ingredient, LBiome. It is an honor to partner with Adare, a company with a legacy of developing and manufacturing innovative products of the highest integrity.”